cancer

In a recent development, the American Cancer Society has widened its lung cancer screening guidelines. This change could potentially result in an additional five million U.S. adults being screened each year. What Happened: As reported by Fortune, the American Cancer Society has revised its lung...

Althea Group Holdings Limited (ASX: AGH), an Australian manufacturer of cannabis-based medicines and recreational cannabis products confirmed that Ireland’s Primary Care Reimbursement Service (‘PCRS’) has approved Althea THC20:CBD1 cannabis oil for...

Merck & Company, Inc. (NYSE: MRK) and Japan's Daiichi Sankyo Co. Ltd. (OTC: DSKYF) entered into a global development and commercialization agreement. The companies are developing three of Daiichi Sankyo's DXd antibody-drug conjugate (ADC) candidates for patients...

EO Care, a provider of clinically guided cannabis health and wellness solutions has been selected as the cannabis care content partner for the non-profit organization Twist Out Cancer. See Also: Exploring Cannabis For Cancer: Hope, Hype Or Healing? The Latest Research And Treatment Options...

Shares of Guardant Health Inc (NASDAQ: GH) climbed during the premarket trading session and morning on Wednesday. Proprietary industry checks suggested the company could sustain around 20% growth for “a number of years,” given its strong position in profiling, according to...

This story was first published on the Benzinga India portal. It’s not uncommon to see headlines about large pharmaceutical companies being sued in the U.S. — after all, the healthcare industry walks the tightrope between profit and saving lives. However, few may have expected India...

On Friday, Tesla CEO Elon Musk reacted after WHO said aspartame — a key ingredient in Diet Coke — could potentially cause cancer. What Happened: "I'd be dead long ago if aspartame was dangerous," the billionaire wrote on his social media platform Twitter.  See Also: Elon Musk Laughs As Mark...

An artificial intelligence (AI) tool, the Cryosection Histopathology Assessment and Review Machine (CHARM), is showing promise in aiding doctors in the fight against aggressive brain tumors. CHARM can quickly identify the genetic profile of a glioma tumor, a process that currently takes days or...

In a recent report, Bank of America identified the “Disruptive Dozen” emerging technologies that have the most potential to disrupt and revolutionize the healthcare sector over the next years. New therapy for ALS (amyotrophic lateral sclerosis) and a blood test for Alzheimer’s...

Patients across the United States are facing a critical shortage of chemotherapy drugs, specifically platinum-based generic drugs cisplatin and carboplatin, used to treat various types of cancers, Dr. Kristen Rice writes in a STAT News opinion piece. The Shortage: According to Dr. Rice, a medical...

Recent reports from two drug companies that had been conducing separate clinical trials to evaluate cancer treatments reveal that the trials were halted due to the deaths of six participants, including one child.  One of the trials had focused on assessing a potential treatment...

Key Takeaways: Junshi Biosciences reported dismal results in the first quarter, with operating income plunging nearly 60% and its net loss expanding by 37% Hopes of a big revenue boost from an oral Covid drug have been dashed, and the company may not recoup its investment in the short term By...

Shares of ImmunityBio (NASDAQ: IBRX) were down 55.1% on Thursday after management announced that FDA issued a complete response letter ("CRL") to its biologics license application ("BLA") seeking approval for the combination use of its lead pipeline candidate, Anktiva (N-...

Results from an advanced clinical trial assessing psilocybin-assisted therapy for patients with cancer and Major Depressive Disorder (MDD) conducted by oncology center Sunstone Therapies were published in the acclaimed JAMA Oncology. The open-label Phase 2 study tested psilocybin paired with ...

This article was originally published on Psychedelic Spotlight and appears here with permission. A general review of 13 studies found that when coupled with conventional cancer treatments, patients given anywhere from 1-3.6 grams of turkey tail mushroom every day experienced a 9% reduction in 5-...